Krebs Biochemicals and Industries Limited approved Re-constitution of Audit Committee: With the above changes in the Board Composition, the Audit Committee of the Company is re-constitute with effect from 10th August, 2023 is as under: Mr. GVL Prasad - Non-Executive & Independent Director /Chairman of the Committee, Mr. Satish Khivsara - Non-Executive & Independent Director, Dr. Malati Tangirala - Non-Executive & Independent Director, Mr. Jitendra Shah Managing Director & CEO.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.5 INR | +2.44% | -7.00% | -13.84% |
1st Jan change | Capi. | |
---|---|---|
-13.84% | 17.01M | |
+21.09% | 43.27B | |
+25.28% | 22.92B | |
+19.22% | 15.43B | |
+13.51% | 12.95B | |
+44.01% | 11.83B | |
-7.79% | 6.91B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+13.02% | 5.55B |
- Stock Market
- Equities
- KREBSBIO Stock
- News Krebs Biochemicals & Industries Limited
- Krebs Biochemicals Limited Announces Executive Changes, Effective 10 August 2023